GHOSH ANIRVAN (Chief Executive Officer) received a stock award from UNITY BIOTECHNOLOGY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/31/2025ACC: 0000950170-25-047731
DirectorOfficer· Chief Executive Officer
Since Mar 2020
+461K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
461K acquired
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
+175K
Price / share
—
Trade value
—
% of position
232.6%
3/28/2025
75.25K→250.25K
Total
Net shares
+175K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 3/28/2025 | A · Award | +175K | — | — | 232.6% | 75.25K | 250.25K |
| Total | +175K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
286K shares
Shares
+286K
Strike price
1.67
Held after
286K
Exercisable
—
3/28/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock286K shares | 3/28/2025 | A · Award | +286K | 1.67 | — | 286K |